ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“ELCC26 is more than a congress. It’s a global platform where innovation meets collaboration.
You are not just sharing data, you are contributing to a dialogue that drives progress and improves patient outcomes worldwide.
Abstract submissions are open until Tuesday, 13 January, 21:00 CET.
Submit your abstract today.
Don’t miss the chance to showcase your work among leading experts and peers in lung cancer.”
More posts featuring ELCC26.